Development of a customised programme to standardise comorbidity diagnosis codes in a large-scale database

por Osorio, Robert C, Raygor, Kunal P, Abla, Adib A
Publicado 2022

Metabolic Barriers to Glioblastoma Immunotherapy

por Choudhary, Nikita, Osorio, Robert C., Oh, Jun Y., Aghi, Manish K.
Publicado 2023

United Network for Organ Sharing regional variations in appeal denial rates with non‐standard Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exceptions: suppor...

por Gish, Robert G., Wong, Robert J., Honerkamp‐Smith, Gordon, Xu, Ronghui, Osorio, Robert W.
Publicado 2015

Pituitary adenomas and cerebrovascular disease: A review on pathophysiology, prevalence, and treatment

por Osorio, Robert C., Oh, Jun Y., Choudhary, Nikita, Lad, Meeki, Savastano, Luis, Aghi, Manish K.
Publicado 2022

Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells

por Oh, Jun Y., Osorio, Robert C., Jung, Jangham, Carrete, Luis, Choudhary, Nikita, Lad, Meeki, Saha, Atul, Aghi, Manish K.
Publicado 2022

Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication Stress

por Bezrookove, Vladimir, Patino, John M., Nosrati, Mehdi, Desprez, Pierre-Yves, McAllister, Sean, Soroceanu, Liliana, Baron, Ari, Osorio, Robert, Kashani-Sabet, Mohammed, Dar, Altaf A.
Publicado 2021

Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9

por Saqub, Hera, Proetsch-Gugerbauer, Hannah, Bezrookove, Vladimir, Nosrati, Mehdi, Vaquero, Edith M., de Semir, David, Ice, Ryan J., McAllister, Sean, Soroceanu, Liliana, Kashani-Sabet, Mohammed, Osorio, Robert, Dar, Altaf A.
Publicado 2020

Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma

por Ursu, Sarah, Majid, Shahana, Garger, Caroline, de Semir, David, Bezrookove, Vladimir, Desprez, Pierre-Yves, McAllister, Sean, Soroceanu, Liliana, Nosrati, Mehdi, Yimam, Kidist, Hassoun, Assad, Osorio, Robert, Kashani-Sabet, Mohammed, Dar, Altaf A.
Publicado 2019